Vanda Pharmaceuticals Inc (STU:VM4)
€ 5.45 -0.11 (-1.98%) Market Cap: 329.51 Mil Enterprise Value: 163.34 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 75/100

Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2026 / 05:00 PM GMT
Release Date Price: €6.35 (-3.05%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VNDA.OQ - Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference
Jan 15, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everybody.

Thank you so much for joining us on day 4 of the JPMorgan Healthcare conference. My name is Pavna Balakrishnan, and I'm an associate in the Healthcare Investment Banking Group.

Today we're joined by Vanda Pharmaceuticals, and we have with us Kevin Moran, senior Vice President, Chief Financial Officer, and treasurer. Over to you, Kevin. Wonderful.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and thank you very much to the entire JPMorgan team for having us here this week.

So we'll begin our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot